Kornitzer Capital Management Inc Bio Techne Corp Transaction History

Kornitzer Capital Management Inc

$5.1 Billion
Q2 2024

A detailed history of Kornitzer Capital Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 231,435 shares of TECH stock, worth $18.5 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

231,435

Previous 230,375 0.46%

Holding current value

$18.5 Million

Previous $16.2 Million 2.26%

% of portfolio

0.32%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$62.12 - $84.15 $65,847 - $89,199	1,060 Added 0.46%	231,435 $16.6 Million
Q1 2024 May 01, 2024	SELL	$65.98 - $77.09 $989,700 - $1.16 Million	-15,000 Reduced 6.11%	230,375 $16.2 Million
Q4 2023 Jan 31, 2024	BUY	$52.83 - $78.22 $2.78 Million - $4.12 Million	52,712 Added 27.36%	245,375 $18.9 Million
Q3 2023 Oct 31, 2023	BUY	$67.52 - $89.42 $42,537 - $56,334	630 Added 0.33%	192,663 $13.1 Million
Q2 2023 Aug 01, 2023	BUY	$73.76 - $85.98 $354,490 - $413,219	4,806 Added 2.57%	192,033 $15.7 Million
Q1 2023 May 09, 2023	BUY	$71.62 - $86.62 $8.89 Million - $10.7 Million	124,082 Added 196.5%	187,227 $13.9 Million
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $3.84 Million - $16.8 Million	47,628 Added 306.94%	63,145 $5.23 Million
Q3 2022 Nov 03, 2022	SELL	$282.54 - $391.85 $762,010 - $1.06 Million	-2,697 Reduced 14.81%	15,517 $4.41 Million
Q2 2022 Aug 03, 2022	SELL	$322.67 - $449.65 $283,304 - $394,792	-878 Reduced 4.6%	18,214 $6.31 Million
Q1 2022 Apr 27, 2022	SELL	$353.85 - $487.79 $149,678 - $206,335	-423 Reduced 2.17%	19,092 $8.27 Million
Q4 2021 Feb 01, 2022	SELL	$456.15 - $525.06 $77,545 - $89,260	-170 Reduced 0.86%	19,515 $10.1 Million
Q3 2021 Nov 03, 2021	SELL	$444.87 - $538.88 $444,870 - $538,880	-1,000 Reduced 4.83%	19,685 $9.54 Million
Q1 2021 Apr 30, 2021	SELL	$314.62 - $411.0 $20,450 - $26,715	-65 Reduced 0.31%	20,685 $7.9 Million
Q4 2020 Jan 29, 2021	SELL	$246.9 - $321.87 $7.96 Million - $10.4 Million	-32,235 Reduced 60.84%	20,750 $6.59 Million
Q3 2020 Oct 30, 2020	SELL	$232.22 - $282.96 $514,135 - $626,473	-2,214 Reduced 4.01%	52,985 $13.1 Million
Q2 2020 Aug 03, 2020	SELL	$185.43 - $279.56 $24.1 Million - $36.4 Million	-130,073 Reduced 70.21%	55,199 $14.6 Million
Q1 2020 Apr 30, 2020	SELL	$161.17 - $221.51 $2.25 Million - $3.1 Million	-13,986 Reduced 7.02%	185,272 $35.1 Million
Q4 2019 Jan 31, 2020	BUY	$189.68 - $222.09 $754,926 - $883,918	3,980 Added 2.04%	199,258 $43.7 Million
Q3 2019 Nov 04, 2019	SELL	$183.56 - $216.72 $2.01 Million - $2.37 Million	-10,941 Reduced 5.31%	195,278 $38.2 Million
Q2 2019 Jul 31, 2019	SELL	$188.72 - $215.43 $8.95 Million - $10.2 Million	-47,425 Reduced 18.7%	206,219 $43 Million
Q1 2019 May 01, 2019	SELL	$136.09 - $200.44 $395,749 - $582,879	-2,908 Reduced 1.13%	253,644 $50.4 Million
Q4 2018 Jan 31, 2019	SELL	$132.75 - $203.8 $2.9 Million - $4.45 Million	-21,816 Reduced 7.84%	256,552 $37.1 Million
Q3 2018 Nov 13, 2018	BUY	$147.44 - $204.11 $21.9 Million - $30.3 Million	148,297 Added 114.01%	278,368 $56.8 Million
Q2 2018 Aug 02, 2018	BUY	$144.9 - $165.58 $1.31 Million - $1.5 Million	9,058 Added 7.49%	130,071 $19.2 Million
Q1 2018 Apr 30, 2018	SELL	$131.46 - $151.04 $1.68 Million - $1.93 Million	-12,785 Reduced 9.56%	121,013 $18.3 Million
Q4 2017 Jan 31, 2018	SELL	$121.17 - $134.75 $2.18 Million - $2.43 Million	-18,005 Reduced 11.86%	133,798 $17.3 Million
Q3 2017 Oct 31, 2017	BUY	$113.59 - $123.78 $17.2 Million - $18.8 Million	151,803	151,803 $18.4 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.13B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Bio Techne Corp Transaction History